- Home
- / 23andMe
23andMe
Subscribers
425 K
FY, 2022
Revenue
$271.9 M
FY, 2022
Market Capitalization
$1.4 B
2022-09-19
23andMe Summary
Company summary
- Overview
- 23andMe Holding is a consumer genetics and research company. It helps individuals to understand their own genetic information through DNA analysis technologies and web-based interactive tools. The сompany enables people to gain insights into their ancestry and genetic makeup.
- Type
- Public
- Founded
- 2006
- HQ
- South San Francisco, CA, US | view all locations
- Website
- https://23andme.com
- Cybersecurity rating
- ESG rating
- out of 100 | View all ESG data
Key people
Steve Schoch, Chief Financial Officer
Kathy Hibbs, Chief Legal and Regulatory Officer
Kenneth Hillan, Chief Therapeutics Officer
Operating MetricsView all
Countries
50
Apr, 2020
Customers
10M
Apr, 2020
DNA Kits Sold
10M
Feb, 2020
23andMe Financials
Summary financials
- Revenue (FY, 2022)
- $271.9M
- Gross profit (FY, 2022)
- $132.9M
- Net income (FY, 2022)
- ($217.5M)
- Cash (FY, 2022)
- $553.2M
- EBIT (FY, 2022)
- ($254.2M)
- Enterprise value
- $941.9M
